Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

NCT00338091 is registered in ClinicalTrials.gov with Southern Medical University, China as lead sponsor.

NCT NCT00338091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00338091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
Lead sponsor
Southern Medical University, China
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2002
Completion date
May 31, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ace inhibitor, angiotensin ii type 1 receptor blockers, disease progression, dose-response relationship,drug, proteinuria, renal insufficiency,chronic